Login / Signup
Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with chronic urticaria.
Lotte S Spekhorst
J M P A van den Reek
A C Knulst
Heike Röckmann
Published in:
Allergy (2019)
Keyphrases
</>
primary care
healthcare
physical activity
free survival
quality improvement
adverse drug